The genetic association of variants in CD6, TNFRSF1A and IRF8 to multiple sclerosis: A multicenter case-control study

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Leppä, Virpi ^a,b   Surakka, Ida ^a,b   Tienari, Pentti J ^a   Elovaara, Irina ^c   Compston, Alastair ^d   Sawcer, Stephen ^d   Robertson, Neil ^e   de Jager, Philip L ^f,g   Aubin, Cristin ^g   Hafler, David A ^g,h   Oturai, Annette Bang ⁱ   Søndergaard, Helle Bach ⁱ   Sellebjerg, Finn ⁱ   Sørensen, Per Soelberg ⁱ   Hemmer, Bernhard ^j   Cepok, Sabine ^j   Winkelmann, Juliane ^j,k,l   Wichmann, Heinz Erich ^l,m   Comabella, Manuel ⁿ   Bustamante, Marta F ⁿ   Montalban, Xavier ⁿ   Olsson, Tomas ^o   Kockum, Ingrid ^o   Hillert, Jan ^o   Alfredsson, Lars ^o   Goris, An ^p   Dubois, Bénédicte ^p   Mero, Inger Lise ^q   Smestad, Cathrine ^q   Celius, Elisabeth G ^q   Harbo, Hanne F ^q,r   D'Alfonso, Sandra ^s   Bergamaschi, Laura ^s   Leone, Maurizio ^t   Ristori, Giovanni ^u   Kappos, Ludwig ^v   Hauser, Stephen L ^w   Cournu Rebeix, Isabelle ^x,y   Fontaine, Bertrand ^x,y   Boonen, Steven ^z   Polman, Chris ^aa   Palotie, Aarno ^a,g,ab   Peltonen, Leena ^a,b,g,ab   Saarela, Janna ^a,b,ac   more..

^a UNIVERSITY OF HELSINKI   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e CARDIFF UNIVERSITY   (United Kingdom)

^f HARVARD MEDICAL SCHOOL   (United States)

^g BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^h YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF COPENHAGEN   (Denmark)

^j TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^k TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^l INSTITUTE OF EPIDEMIOLOGY   (Germany)

^m UNIVERSITY OF MUNICH   (Germany)

ⁿ HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^o KAROLINSKA INSTITUTE   (Sweden)

^p UNIVERSITY OF LEUVEN   (Belgium)

^q OSLO UNIVERSITY HOSPITAL   (Norway)

^r UNIVERSITY OF OSLO   (Norway)

^s UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^t MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

^u SAPIENZA UNIVERSITY OF ROME   (Italy)

^v UNIVERSITY HOSPITAL BASEL   (Switzerland)

^w UNIVERSITY OF CALIFORNIA   (United States)

^x INSTITUT DU CERVEAU ET DE LA MOELLE ÉPINIÈRE   (France)

^y CNRS   (France)

^z UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^aa VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^ab WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^ac HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CD6 ANTIGEN; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 1A; UNCLASSIFIED DRUG; INTERFERON REGULATORY FACTOR; LEUKOCYTE ANTIGEN; T LYMPHOCYTE ANTIGEN; TNFRSF1A PROTEIN, HUMAN; TUMOR NECROSIS FACTOR RECEPTOR 1;

ARTICLE; CASE CONTROL STUDY; CD6 GENE; GENE; GENE LOCUS; GENE MAPPING; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; IRF8 GENE; MULTIPLE SCLEROSIS; PATHOGENESIS; SINGLE NUCLEOTIDE POLYMORPHISM; TNFRSF1A GENE; GENETICS; MULTICENTER STUDY;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CASE-CONTROL STUDIES; HUMANS; INTERFERON REGULATORY FACTORS; MULTIPLE SCLEROSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I;

EID: 79960334826     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018813     Document Type: Article

References (32)

1. Jersild C, Fog T, (1972) Histocompatibility (HL-A) antigens associated with multiple sclerosis. Acta Neurol Scand Suppl 51: 377.
2. IMSGC (2007) Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 357: 851-862.
3. De Jager PL, Baecher-Allan C, Maier LM, Arthur AT, Ottoboni L, et al. (2009) The role of the CD58 locus in multiple sclerosis. Proc Natl Acad Sci U S A 106: 5264-5269.
4. IMSGC (2009) The expanding genetic overlap between multiple sclerosis and type I diabetes. Genes Immun 10: 11-14.
5. Burton PR, Clayton DG, Cardon LR, Craddock N, Deloukas P, et al. (2007) Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 39: 1329-1337.
6. Jakkula E, Leppa V, Sulonen AM, Varilo T, Kallio S, et al. (2010) Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene. Am J Hum Genet 86: 285-291.
7. IMSGC (2010) Comprehensive follow-up of the first genome-wide association study of multiple sclerosis identifies KIF21B and TMEM39A as susceptibility loci. Hum Mol Genet 19: 953-962.
8. ANZgene (2009) Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat Genet 41: 824-828.
9. Sanna S, Pitzalis M, Zoledziewska M, Zara I, Sidore C, et al. (2010) Variants within the immunoregulatory CBLB gene are associated with multiple sclerosis. Nat Genet 42: 495-497.
10. IMSGC (2010) IL12A, MPHOSPH9/CDK2AP1 and RGS1 are novel multiple sclerosis susceptibility loci. Genes Immun 11: 397-405.
11. De Jager PL, Jia X, Wang J, de Bakker PI, Ottoboni L, et al. (2009) Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat Genet 41: 776-782.
12. Lao O, Lu TT, Nothnagel M, Junge O, Freitag-Wolf S, et al. (2008) Correlation between genetic and geographic structure in Europe. Curr Biol 18: 1241-1248.
13. Nelis M, Esko T, Magi R, Zimprich F, Zimprich A, et al. (2009) Genetic structure of Europeans: a view from the North-East. PLoS One 4: e5472.
14. Novembre J, Johnson T, Bryc K, Kutalik Z, Boyko AR, et al. (2008) Genes mirror geography within Europe. Nature 456: 98-101.
15. Kazeem GR, Farrall M, (2005) Integrating case-control and TDT studies. Ann Hum Genet 69: 329-335.
16. Baranzini SE, Galwey NW, Wang J, Khankhanian P, Lindberg R, et al. (2009) Pathway and network-based analysis of genome-wide association studies in multiple sclerosis. Hum Mol Genet 18: 2078-2090.
17. Sharfe N, Dadi HK, Shahar M, Roifman CM, (1997) Human immune disorder arising from mutation of the alpha chain of the interleukin-2 receptor. Proc Natl Acad Sci U S A 94: 3168-3171.
18. Puel A, Ziegler SF, Buckley RH, Leonard WJ, (1998) Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency. Nat Genet 20: 394-397.
19. Minegishi Y, Saito M, Morio T, Watanabe K, Agematsu K, et al. (2006) Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. Immunity 25: 745-755.
20. Minegishi Y, Saito M, Tsuchiya S, Tsuge I, Takada H, et al. (2007) Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature 448: 1058-1062.
21. Ryan JG, Aksentijevich I, (2009) Tumor necrosis factor receptor-associated periodic syndrome: toward a molecular understanding of the systemic autoinflammatory diseases. Arthritis Rheum 60: 8-11.
22. Kumpfel T, Hoffmann LA, Rubsamen H, Pollmann W, Feneberg W, et al. (2007) Late-onset tumor necrosis factor receptor-associated periodic syndrome in multiple sclerosis patients carrying the TNFRSF1A R92Q mutation. Arthritis Rheum 56: 2774-2783.
23. Micheau O, Tschopp J, (2003) Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114: 181-190.
24. Suvannavejh GC, Lee HO, Padilla J, Dal Canto MC, Barrett TA, et al. (2000) Divergent roles for p55 and p75 tumor necrosis factor receptors in the pathogenesis of MOG(35-55)-induced experimental autoimmune encephalomyelitis. Cell Immunol 205: 24-33.
25. van Oosten BW, Barkhof F, Truyen L, Boringa JB, Bertelsmann FW, et al. (1996) Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2. Neurology 47: 1531-1534.
26. Whitney GS, Starling GC, Bowen MA, Modrell B, Siadak AW, et al. (1995) The membrane-proximal scavenger receptor cysteine-rich domain of CD6 contains the activated leukocyte cell adhesion molecule binding site. J Biol Chem 270: 18187-18190.
27. Sewell WA, Palmer RW, Spurr NK, Sheer D, Brown MH, et al. (1988) The human LFA-3 gene is located at the same chromosome band as the gene for its receptor CD2. Immunogenetics 28: 278-282.
28. Singer NG, Fox DA, Haqqi TM, Beretta L, Endres JS, et al. (2002) CD6: expression during development, apoptosis and selection of human and mouse thymocytes. Int Immunol 14: 585-597.
29. Nelson N, Marks MS, Driggers PH, Ozato K, (1993) Interferon consensus sequence-binding protein, a member of the interferon regulatory factor family, suppresses interferon-induced gene transcription. Mol Cell Biol 13: 588-599.
30. Tamura T, Nagamura-Inoue T, Shmeltzer Z, Kuwata T, Ozato K, (2000) ICSBP directs bipotential myeloid progenitor cells to differentiate into mature macrophages. Immunity 13: 155-165.
31. Holtschke T, Lohler J, Kanno Y, Fehr T, Giese N, et al. (1996) Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene. Cell 87: 307-317.
32. Wang H, Lee CH, Qi C, Tailor P, Feng J, et al. (2008) IRF8 regulates B-cell lineage specification, commitment, and differentiation. Blood 112: 4028-4038.